Skip to main content

Market Overview

Thoratec Shareholders Approve St. Jude Medical's Acquisition Of Thoratec


Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that all proposals necessary for St. Jude Medical, Inc.'s acquisition of Thoratec Corporation were approved by Thoratec Corporation's shareholders at its shareholder meeting held today.

As previously announced, on July 21, 2015, Thoratec and St. Jude Medical entered into a definitive agreement by which St. Jude Medical will acquire Thoratec. Under the terms of the transaction, Thoratec shareholders will receive $63.50 in cash for each Thoratec share.

Thoratec expects that the transaction will close on October 8, 2015.


Related Articles (THOR)

View Comments and Join the Discussion!

Posted-In: News Press Releases

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at